PODD
Insulet Corporation
$149.01
+0.60%
2026-10-23
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Key Fundamentals
P/E Ratio
25.49
Forward P/E
17.66
EPS (TTM)
$5.34
ROE
26.0%
Revenue Growth (YoY)
23.5%
Profit Margin
12.3%
Debt/Equity
66.69
Price/Book
6.64
Beta
1.08
Market Cap
$9.44B
Avg Volume (10D)
1.5M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$172.11
60D Low
$126.40
Avg Volume
1.7M
Latest Close
$149.01
Get breakout alerts for PODD
Sign up for Breakout Scanner to receive daily notifications when PODD triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Insulet Corporation (PODD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PODD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PODD operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.